FBRX
Forte Biosciences Inc
77.00$
+0.0%
vs. previous close
Closing price · As of: Aug 28, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +100.0% | +50.0% | +11.1% | +0.0% | +0.0% | +30.0% | +15.4% | +13.3% | +11.8% | +0.0% | +5.3% | – | |
| – | +1.0% | +3.2% | -0.4% | -1.4% | -11.9% | +132.4% | -7.7% | -1.1% | +12.5% | +90.9% | -200.0% | – | |
| – | -1,721.2% | – | – | -109.6% | – | – | -108.2% | – | +155.2% | -97.5% | -1,550.4% | – | |
| – | -76.1% | -64.7% | -100.0% | – | – | +96.8% | -100.0% | – | -100.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +212.5% | +21,233.3% | -37.5% | -90.0% | +100.0% | – | – | – | – | – | – | – | |
| – | -100.3% | -89.3% | +25.0% | -80.0% | – | -104.5% | – | -98.1% | -99.3% | +722.2% | +218,750.0% | – | |
| – | -1,400.7% | – | – | – | – | +301.5% | +155.3% | -121.1% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.